Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market ...

TORONTO (AP) — TORONTO (AP) — Organigram Global Inc. (OGI) on Wednesday reported a loss of $4.5 million in its fiscal third quarter. On a per-share basis, the Toronto-based company said it had a loss ...

Organigram's Q3 sales rose 72% to $51.14 million, driven by Motif acquisition and global demand, with margin gains and positive cash flow expected.

OrganiGram (OGI) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.02 per share a year ago. These figures are ...

Analysts expect OrganiGram Holdings to report an earnings per share (EPS) of $-0.01. The announcement from OrganiGram Holdings is eagerly anticipated, with investors seeking news of surpassing ...

Reports Q3 adjusted EBITDA $5.694M vs. $3.465M. “In Q3, we delivered our second consecutive quarter of record revenue driven by the acquisition of ...

Trump said on Monday a decision could come within the next couple of weeks. Under the Controlled Substances Act, marijuana is ...

Find out all the key statistics for Organigram Global Inc. (OGI), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.